Cargando…
Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency in Vitro
Pancreatic cancer is among the most aggressive human cancers, and is resistant to regular chemotherapy and radiotherapy. The AT-rich interactive domain containing protein 1A (ARID1A) gene, a crucial chromatin remodeling gene, mutates frequently in a broad spectrum of cancers, including pancreatic ca...
Autores principales: | Yang, Lin, Yang, Guanghai, Ding, Yingjun, Dai, Yuhong, Xu, Sanpeng, Guo, Qiuyun, Xie, Aini, Hu, Guangyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868153/ https://www.ncbi.nlm.nih.gov/pubmed/29581767 http://dx.doi.org/10.7150/jca.21306 |
Ejemplares similares
-
Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma
por: Tessiri, Supharada, et al.
Publicado: (2022) -
Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
por: Samartzis, Eleftherios P, et al.
Publicado: (2014) -
Overexpression of IGFBP5 Enhances Radiosensitivity Through PI3K-AKT Pathway in Prostate Cancer
por: Chen, Xue, et al.
Publicado: (2020) -
Notch1 ablation radiosensitizes glioblastoma cells
por: Han, Na, et al.
Publicado: (2017) -
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors
por: Rehman, Hasibur, et al.
Publicado: (2022)